Concepedia

Yukinori Takenaka

YT

Statistics

Publications

41

Citations

2.8K

H-Index

24

Active since

1995

Affiliations

The University of Osaka(Current)

The Barbara Ann Karmanos Cancer Institute

Osaka Prefectural Medical Center

Wayne State University

Osaka City General Hospital

Yukinori Takenaka is an author at The University of Osaka specializing in oncology, medicine, and squamous cell carcinoma.

ORCID

Publications per year

1995–2025

41

Publications

41

CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.

Tomoharu Fukumori, Yukinori Takenaka, Tadashi Yoshii et al. · PubMed · 2003 · 367 citations

, , +17

Nuclear Export of Phosphorylated Galectin-3 Regulates Its Antiapoptotic Activity in Response to Chemotherapeutic Drugs

Yukinori Takenaka, Tomoharu Fukumori, Tadashi Yoshii et al. · Molecular and Cellular Biology · 2004 · 232 citations · Full text

, , +14

Galectin-3, a Novel Binding Partner of β-Catenin

Tatsuo Shimura, Yukinori Takenaka, Souichi Tsutsumi et al. · Cancer Research · 2004 · 226 citations

, , +17

Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.

Yuichiro Honjo, Hidenori Inohara, Shiro Akahani et al. · PubMed · 2000 · 160 citations

, , +17

Implication of Galectin-3 in Wnt Signaling

Tatsuo Shimura, Yukinori Takenaka, Tomoharu Fukumori et al. · Cancer Research · 2005 · 151 citations · Full text

, , +13

1–5 of 41